scholarly journals Evaluation of Eosinophilic Cationic Protein and Some Immunological Markers in Patients Infected with Scabies

2019 ◽  
Vol 13 (3) ◽  
pp. 1737-1743 ◽  
Author(s):  
Ali A. Mohy ◽  
Ahmed Abduljabbar Jaloob Aljanaby ◽  
Saleem Khteer Al-Hadraawy
Keyword(s):  
Eosinophilic Cationic Protein ◽  
Cationic Protein ◽  
Immunological Markers

Eosinophilic Cationic Protein in Chronic Eosinophilic Pneumonia and Eosinophilic Granuloma

CHEST Journal ◽  
1994 ◽  
Vol 106 (5) ◽  
pp. 1481-1486 ◽  
Author(s):  
Noriharu Shijubo ◽  
Katsunori Shigehara ◽  
Michio Hirasawa ◽  
Manabu Inuzuka ◽  
Shosaku Abe
Keyword(s):  
Eosinophilic Granuloma ◽  
Eosinophilic Pneumonia ◽  
Eosinophilic Cationic Protein ◽  
Cationic Protein ◽  
Chronic Eosinophilic Pneumonia

Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough

2021 ◽  
Author(s):  
Mara DE AMICI ◽  
Davide PILONI ◽  
Claudio TIRELLI ◽  
Francesca MARIANI ◽  
Giulia ACCORDINO ◽  
...  
Keyword(s):  
Chronic Cough ◽  
Clinical Work ◽  
Eosinophilic Cationic Protein ◽  
Cationic Protein ◽  
Work Up

scholarly journals Serum Eosinophilic cationic protein (ECP) as an effective biological marker to monitor therapy in bronchial asthma patients.

2011 ◽  
Vol 5 (1) ◽  
pp. 3-7 ◽  
Author(s):  
Afroza Begum ◽  
Humayun Sattar ◽  
Abu Naser Ibne Sattar ◽  
Md. Ruhul Amin Miah ◽  
Ahmed Abu Saleh
Keyword(s):  
Bronchial Asthma ◽  
Persistent Asthma ◽  
Biological Marker ◽  
Forced Expiratory Volume ◽  
Asthma Therapy ◽  
Eosinophilic Cationic Protein ◽  
Cationic Protein ◽  
Before And After ◽  
Asthma Patients

Clinically diagnosed bronchial asthma patients comprising of new cases, on therapy or follow up were enrolled for this study to see if the new biological marker Eosinophilic cationic protein (ECP) can be used as a more precise marker to monitor therapy than the presently used conventional ones like FEV1% predicted, PEFR, and Circulating eosinophil (C.E) count. Out of 70 bronchial asthma patients, 30 intermittent, 4 mild persistent, 24 moderate persistent and 12 severe persistent asthma patients were included, while 45 cases were enrolled for follow up. Serum level of eosinophil granular protein, Eosinophilic cationic protein (ECP) was measured in relation to changes in their forced expiratory volume in 1st second (FEV1% predicted) and Circulating Eosinophil count (%) before and after therapy in 45 follow up patients on asthma therapy. In this study, it was observed that C.E count (%) and FEV1% predicted were not decreased significantly and serum eosinophilic cationic protein (ECP) decreased significantly (p<0.001) after asthma therapy. Thus, serum ECP level can be used as a biological marker than other conventionally used marker (FEV1, C.E count) to monitor therapeutic efficacy in bronchial asthma patients.DOI: http://dx.doi.org/10.3329/bjmm.v5i1.15813 Bangladesh J Med Microbiol 2011; 05 (01): 3-7

Serum Eosinophilic Cationic Protein: Is There a Role in Respiratory Disorders?

2010 ◽  
Vol 47 (2) ◽  
pp. 131-134 ◽  
Author(s):  
Vittoria Peona ◽  
Mara De Amici ◽  
Silvana Quaglini ◽  
Gianluca Bellaviti ◽  
Anna Maria Castellazzi ◽  
...  
Keyword(s):  
Eosinophilic Cationic Protein ◽  
Cationic Protein ◽  
Respiratory Disorders
Sign in / Sign up

Export Citation Format

Share Document